Urinary Tract Infections (UTIs)

2

Review clinical trials related to Urinary Tract Infections (UTIs). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

INterest of the Negative Predictive Value of Integrons in the reduCtion of Large Broad-spectrum anTibiotics Consumption for Urinary Tract infectionS

Urinary tract infections (UTI), mainly driven by Gram-negative bacteria (GNB) are a frequent cause of hospitalization and the second cause of antibiotic prescription after lower respiratory tract infections. Integrons play a major role in the dissemination of antibiotic resistance among GNB. In the prospective INVICTUS project, whose ultimate objective is to reduce the use of large broad-spectrum antibiotics, our hypothesis is that, in adult patients with a non-severe UTI (qSOFA\<2) and a former documentation with a 3GC-resistant GNB in the previous 6 months, integrons search could reduce the empirical use of large broad-spectrum antibiotics.

Participants needed: 204
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, LimogesUpdated: Jul 1, 2026Locations: 7
Eligibility criteria

Age ≥ 18 years old; Hospitalized or admitted to the Emergency department; [+5]

Pregnant and/or breastfeeding [+7]

Status: Not yet recruiting

Antibiofilm Activity of Chitosan Nanoparticles Against Uropathogenic Escherichia Coli

1. Isolation of uropathogenic Escherichia coli (UPEC) and determination of their Antimicrobial sensitivity Patterns. 2. Evaluation of biofilm-forming capacity of UPEC isolates. 3. Assessment of the antibiofilm efficacy of chitosan nanoparticles alone and in combination with ciprofloxacin against UPEC isolates. 4. Examination of the effectiveness of chitosan nanoparticle coating in preventing biofilm formation by UPEC on urinary catheter surfaces. 5. Evaluation of the impact of chitosan nanoparticles on the expression levels of biofilm associated genes in UPEC.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Assiut UniversityUpdated: Mar 27, 2026Locations: 1
Eligibility criteria

1. Patients (inpatients or outpatients) clinically diagnosed with urinary tract...

1. Patients who received systemic antibiotic therapy within the previous 48-72 h...